Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
STARD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LRRC58 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DKFZp451B082 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMEM43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF440 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGEE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INPP5J - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIPT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HPS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPSECS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNA2D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102723697 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSMEM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on